Wolfgang Miesbach, MD

Professor and Head of Coagulation Disorders and Comprehensive Care Centre
University Hospital Frankfurt, Frankfurt, Germany

Prof. Dr. med. Miesbach is head of the Department of Coagulation Disorders and the Comprehensive Care Haemophilia Centre at the Goethe University Hospital in Frankfurt/Main, Germany. In addition, he is head of the EAHAD Gene Therapy Working Group and member of gene therapy (GT) steering committees of international societies. His main research interest is in the field of hemophilia with focus on GT and quality of life investigations.

Presentation(s):

• SS 02.2 - What are key Steps Along the Gene Therapy Clinical Trial Treatment Journey for People With Haemophilia?

  Saturday, July 9, 2022
  11:35 AM – 11:55 AM

• SS 07.3 - Are We Ready? Learnings From Other Innovative Therapies

  Sunday, July 10, 2022
  1:40 PM – 2:15 PM

• SS 07.4 - Question & Answer Session

  Sunday, July 10, 2022
  2:15 PM – 2:25 PM

• PB0212 - Collaboration between the World Federation of Hemophilia and National Registries for the Long-Term Follow-up of People with Hemophilia Treated with Gene Therapy

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB1127 - Novel accreditation of European haemophilia treatment and gene therapy centres

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1174 - Eptacog beta for resolution of bleeding episodes in patients with hemophilia A or B with inhibitors: Efficacy and safety according to inhibitor titer

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM